Telix Pharmaceuticals Limited
General ticker "TLX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $3.6B (TTM average)
Telix Pharmaceuticals Limited follows the US Stock Market performance with the rate: 39.6%.
Estimated limits based on current volatility of 2.1%: low 11.88$, high 12.35$
Factors to consider:
- Total employees count: 200000 as of 2024
Short-term TLX quotes
Long-term TLX plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | AUD502.55MM | AUD783.21MM | AUD1,205.43MM |
| Operating Expenses | AUD486.71MM | AUD701.08MM | AUD1,178.78MM |
| Operating Income | AUD15.84MM | AUD82.13MM | AUD26.64MM |
| Non-Operating Income | AUD-12.75MM | AUD-26.07MM | AUD-34.54MM |
| Interest Expense | AUD8.94MM | AUD21.46MM | AUD55.06MM |
| R&D Expense | AUD128.84MM | AUD121.03MM | AUD256.82MM |
| Income(Loss) | AUD3.09MM | AUD56.06MM | AUD-7.90MM |
| Taxes | AUD-2.07MM | AUD6.14MM | AUD2.79MM |
| Net Income(Loss)* | AUD5.21MM | AUD49.92MM | AUD-10.69MM |
| Stockholders Equity | AUD148.91MM | AUD568.21MM | AUD622.27MM |
| Inventory | AUD17.31MM | AUD38.14MM | AUD55.55MM |
| Assets | AUD398.30MM | AUD1,516.43MM | AUD1,770.91MM |
| Operating Cash Flow | AUD23.88MM | AUD43.03MM | AUD-25.93MM |
| Capital expenditure | AUD9.68MM | AUD14.32MM | AUD56.86MM |
| Investing Cash Flow | AUD-25.49MM | AUD-135.17MM | AUD-428.79MM |
| Financing Cash Flow | AUD10.19MM | AUD638.92MM | AUD-5.58MM |
| Earnings Per Share** | AUD0.02 | AUD0.15 | AUD-0.03 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.